Related Experiment Video

Updated: May 30, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid

Dmitriy Ovcharenko1, Friedrich Stölzel, David Poitz

  • 1Asuragen Inc., Austin, Tx., USA.

Experimental Hematology
|July 26, 2011
PubMed
Abstract

Insights

MicroRNA-10a (miR-10a) is significantly elevated in acute myeloid leukemia (AML) with NPM1 mutations. This upregulation of miR-10a in AML patients may impact disease biology by affecting the MDM4 gene and p53 pathway.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
  • Intermediate-risk (IR) AML often presents complex genetic profiles.
  • MicroRNAs (miRNAs) play crucial roles in gene regulation and cancer development.

Purpose of the Study:

  • To investigate differential miRNA expression in intermediate-risk (IR) acute myeloid leukemia (AML) patients.
  • To characterize the role of miR-10a in NPM1-mutated AML.
  • To elucidate the functional consequences of miR-10a overexpression in vitro.

Main Methods:

  • Microarray analysis of bone marrow samples from AML (IR) patients and healthy donors.
  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) for miRNA validation.
  • In vitro studies including cell transfection, Western blotting, and luciferase reporter assays to identify and validate miR-10a targets.

Main Results:

  • NPM1-mutated AML samples showed marked overexpression of miR-10a compared to wild-type.
  • Overexpression of miR-10a in vitro induced differential gene expression, identifying MDM4 as a candidate target gene.
  • A negative correlation between miR-10a and MDM4 expression was observed in leukemic cells and AML (IR) samples.

Conclusions:

  • miR-10a is a characteristic marker for AML (IR) with NPM1 mutations.
  • miR-10a may influence AML biology by interacting with the p53 regulatory pathway via MDM4.
  • These findings highlight miR-10a as a potential therapeutic target in NPM1-mutated AML.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...